Azulfidine- (sulfasalazine-) induced hepatic injury

Abstract
A patient with Azulfidine-related hepatotoxicity in which prompt recurrence of symptoms, fever, skin rash, and laboratory evidence of hepatocellular injury occurred upon readministration of Azulfidine is reported. The clinical and biochemical features support the fact that this was an example of an acquired hypersensitivity reaction to Azulfidine.